Cargando…

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial

BACKGROUND: Influenza is an important cause of morbidity and mortality worldwide. Treatment options are scarce, and new drugs with novel mechanisms of action are needed. We aimed to assess the efficacy and safety of nitazoxanide, a thiazolide anti-infective, for treatment of acute uncomplicated infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haffizulla, Jason, Hartman, Aaron, Hoppers, Melanie, Resnick, Harvey, Samudrala, Steve, Ginocchio, Christine, Bardin, Matthew, Rossignol, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164783/ https://www.ncbi.nlm.nih.gov/pubmed/24852376 http://dx.doi.org/10.1016/S1473-3099(14)70717-0

Ejemplares similares

A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
por: Rossignol, Jean-François, et al.
Publicado: (2022)

Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
por: Rocco, Patricia R.M., et al.
Publicado: (2021)

Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
por: Rocco, Patricia R. M., et al.
Publicado: (2022)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide
por: DeBoer, Mark Daniel, et al.
Publicado: (2018)

Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.
por: Blum, Vinicius Fontanesi, et al.
Publicado: (2021)

Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza
por: Roberts, Grace, et al.
Publicado: (2019)

Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
por: Hayden, Frederick G, et al.
Publicado: (2022)

A Pilot Clinical Trial of Nitazoxanide in the Treatment of Chronic Hepatitis B
por: Rossignol, Jean‐François, et al.
Publicado: (2019)

The Modulation of Cholesterol Metabolism Is Involved in the Antiviral Effect of Nitazoxanide
por: Fenizia, Claudio, et al.
Publicado: (2021)

Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
por: Rossignol, Jean-François
Publicado: (2016)

Optimising the treatment for uncomplicated acute appendicitis (OPTIMA trial): a protocol for a multicentre, randomised, double-blinded placebo-controlled study
por: Wu, Jie, et al.
Publicado: (2022)

A randomised placebo-controlled double-blind multicentre trial comparing antibiotic therapy with placebo in the treatment of uncomplicated acute appendicitis: APPAC III trial study protocol
por: Sippola, Suvi, et al.
Publicado: (2018)

Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial
por: Kähler, Christian, et al.
Publicado: (2017)

Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)
por: Smith, Tania, et al.
Publicado: (2022)

Effectiveness of a Chinese herbal medicine preparation in the treatment of cough in uncomplicated upper respiratory tract infection: a randomised double-blinded placebo-control trial
por: WCW, Wong, et al.
Publicado: (2006)

Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial()
por: Jansåker, Filip, et al.
Publicado: (2019)

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection
por: Lim, Jeremy J, et al.
Publicado: (2021)

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
por: Blum, Vinicius Fontanesi, et al.
Publicado: (2021)

Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)
por: Smith, Tania A., et al.
Publicado: (2023)

Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial
por: Kronenberg, Andreas, et al.
Publicado: (2017)

Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial
Publicado: (2017)

Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial
por: Matsiégui, Pierre-Blaise, et al.
Publicado: (2008)

The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children
por: Waddington, Claire S, et al.
Publicado: (2018)

Efficacy of Nitazoxanide, Nitazoxanide-Garlic Combination and Tinidazole in Treatment of Giardia duodenalis and Blastocystis hominis: Coproscopic Assessment
por: Abdo, Sarah M., et al.
Publicado: (2023)

Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study
por: Hershberger, Ellie, et al.
Publicado: (2019)

Nitazoxanide is active against Mycobacterium leprae
por: Bailey, Mai Ann, et al.
Publicado: (2017)

Nitazoxanide and COVID-19: A review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Bearberry in the treatment of acute uncomplicated cystitis (BRUMI): protocol of a multicentre, randomised double-blind clinical trial
por: Tóth, Barbara, et al.
Publicado: (2022)

Efficacy and Safety of Nitazoxanide, Albendazole, and Nitazoxanide-Albendazole against Trichuris trichiura Infection: A Randomized Controlled Trial
por: Speich, Benjamin, et al.
Publicado: (2012)

Comparative Efficacy of Diethylcarbamazine, Nitazoxanide and Nanocomposite of Nitazoxanide and Silver Nanoparticles on the Dehydrogenases of TCA Cycle in Setaria cervi, in Vitro
por: KAUSAR, Sharba, et al.
Publicado: (2018)

Antibiotics versus placebo in adults with CT-confirmed uncomplicated acute appendicitis (APPAC III): randomized double-blind superiority trial
por: Salminen, Paulina, et al.
Publicado: (2022)

The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial
por: Simpson, Jodie L., et al.
Publicado: (2014)

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
por: Davey, Richard T, et al.
Publicado: (2019)

Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial
por: Wang, Kay, et al.
Publicado: (2018)

In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide
por: Ashton, Laura V., et al.
Publicado: (2010)

Randomised, Double Blind, Placebo-Controlled Trial of Echinacea Supplementation in Air Travellers
por: Tiralongo, E., et al.
Publicado: (2012)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
por: Fagerström, Karl, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vhq5a5jifqd9lcd80gie4hib1a